ANIK

Peers: BVS LFCR PCRX VCEL ORGO EOLS MDXG CNMD ZBH SNN

| Held by: VTI IWM DFSV VXF IWN FSMD DFAS SCHA VTWO DFMC

Index	RUT
Market Cap	275.69M
Enterprise Value	262.53M
Income	-3.78M
Sales	120.65M
Book/sh	10.26
Cash/sh	2.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	235
IPO	May 03, 1993

P/E	-
Forward P/E	21.68
PEG	0.18
P/S	2.29
P/B	2.01
P/C	7.18
P/FCF	492.30
EV/EBITDA	514.76
EV/Sales	2.18
Quick Ratio	3.19
Current Ratio	4.48
Debt/Eq	0.18
LT Debt/Eq	0.17
Option/Short	Yes / Yes

EPS (ttm)	-0.27
EPS next Y	0.95
EPS next Q	0.42
EPS this Y	854.55%
EPS next Y	-9.52%
EPS next 5Y	118.66%
EPS past 3/5Y	9.40% 14.76%
Sales past 3/5Y	-10.28% -2.86%
EPS Y/Y TTM	93.57%
Sales Y/Y TTM	-2.50%
EPS Q/Q	187.26%
Sales Q/Q	15.56%
Earnings	Jul 29 BMO
EPS/Sales Surpr.	1300.00% 11.62%

Insider Own	6.28%
Insider Trans	2.34%
Inst Own	91.66%
Inst Trans	-0.66%
ROA	-1.68%
ROE	-2.19%
ROIC	-2.36%
Gross Margin	62.16%
Oper. Margin	-4.24%
Profit Margin	-3.14%
SMA20	3.07%
SMA50	-0.39%
SMA200	31.52%
Trades

Shs Outstand	13.38M
Shs Float	12.54M
Short Float	2.93%
Short Ratio	3.41
Short Interest	0.37M
52W High	22.88 -9.97%
52W Low	9.01 128.63%
Volatility	3.08% 3.79%
ATR (14)	0.74
RSI (14)	54.37
Beta	0.23
Rel Volume	0.00
Avg Volume	107.71K
Volume	0

Perf Week	1.73%
Perf Month	-1.39%
Perf Quarter	40.42%
Perf Half Y	32.48%
Perf YTD	114.36%
Perf Year	110.63%
Perf 3Y	9.17%
Perf 5Y	-50.46%
Perf 10Y	-52.81%
Recom	1.00
Target Price	23.00
Prev Close	20.60
Price	20.60
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-18-26	Resumed	B. Riley Securities	Buy	$23
Apr-17-25	Initiated	B. Riley Securities	Buy	$21
Nov-01-24	Reiterated	Barrington Research	Outperform	$37 → $25
Aug-14-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$24
Mar-07-23	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-09-22	Upgrade	Barrington Research	Mkt Perform → Outperform	$31
Oct-14-22	Resumed	Stephens	Equal-Weight	$26
Mar-09-22	Downgrade	Stephens	Overweight → Equal-Weight	$35
Mar-09-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-16-21	Initiated	Stephens	Overweight	$55
Jul-16-21	Initiated	UBS	Neutral	$46
Dec-16-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$43
May-08-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Jan-21-20	Upgrade	Sidoti	Neutral → Buy	$61
Jan-10-20	Upgrade	First Analysis Sec	Outperform → Strong Buy	$65
Nov-05-19	Initiated	BWS Financial	Sell	$29
Sep-24-19	Reiterated	Barrington Research	Outperform	$49 → $58
Sep-23-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$54
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Strong Buy	$37 → $54
Feb-22-19	Downgrade	Sidoti	Buy → Neutral	$56 → $41

Show Previous Ratings

Jul-30-26 01:53PM	These 2 Biotech Stocks Hit New 52-Week Highs Today And CORT Clocked Its Best Day In Nearly 16 Months (Stocktwits) +11.75%
Jul-29-26 05:02PM	Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: Record Revenue and Margin ... (GuruFocus.com) +6.73%
03:16PM	Anika Therapeutics, Inc. Q2 2026 Earnings Call Summary (Moby)
07:20AM	Anika: Q2 Earnings Snapshot (Associated Press)
07:05AM	Anika Reports Second Quarter 2026 Financial Results (GlobeNewswire)
04:01PM	Loading…
Jul-15-26 04:01PM	Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 (GlobeNewswire)
Jun-05-26 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-29-26 12:50PM	Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary (Moby) -18.81%
07:14AM	Anika: Q1 Earnings Snapshot (Associated Press)
07:05AM	Anika Reports First Quarter 2026 Financial Results (GlobeNewswire)
Apr-15-26 04:01PM	Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 (GlobeNewswire)
Apr-07-26 03:35PM	Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization (Exec Edge)
Apr-03-26 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-03-26 03:29AM	Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference (MarketBeat)
Feb-27-26 08:30AM	Anika Therapeutics, Inc. Q4 2025 Earnings Call Summary (Moby) +12.28%
04:09PM	Loading…
Feb-26-26 04:09PM	Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ... (GuruFocus.com) +16.91%
12:15PM	Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates (Zacks)
10:59AM	Anika Therapeutics Q4 Earnings Call Highlights (MarketBeat)
07:35AM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-18-26 04:01PM	Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference (GlobeNewswire)
Feb-12-26 04:01PM	Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 (GlobeNewswire)
Jan-08-26 07:00AM	Anika Therapeutics Announces Leadership Transition (GlobeNewswire)
Nov-06-25 06:00PM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Call Highlights: Strong Growth in Regenerative ... (GuruFocus.com)
Nov-05-25 08:25AM	Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates (Zacks)
07:22AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study (GlobeNewswire)
Nov-04-25 08:43AM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-23-25 04:01PM	Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 (GlobeNewswire)
06:50AM	Loading…
Sep-19-25 06:50AM	Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? (Zacks)
Sep-05-25 05:00AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-29-25 09:55AM	Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High? (Zacks)
Aug-20-25 12:00PM	Anika (ANIK) Upgraded to Buy: Here's What You Should Know (Zacks)
Jul-30-25 08:15AM	Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -27.42%
07:21AM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Second Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast Cartilage Repair Scaffold and Provides Program Update (GlobeNewswire)
Jul-29-25 10:04AM	Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:15AM	uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jul-21-25 10:11AM	Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock? (Zacks)
Jul-16-25 04:01PM	Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 (GlobeNewswire)
Jul-03-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-05-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-12-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:29AM	Company News for May 12, 2025 (Zacks)
May-10-25 03:04AM	Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... (GuruFocus.com)
May-09-25 08:35AM	Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -21.03%
07:44AM	Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 (RTT News)
07:28AM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 09:45AM	Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result (GuruFocus.com)
09:05AM	Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-07-25 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
May-05-25 09:28AM	Is the Options Market Predicting a Spike in Anika Therapeutics Stock? (Zacks)
Apr-25-25 09:00AM	Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 (GlobeNewswire)
Apr-07-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.60%
Apr-03-25 08:44AM	Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? (Zacks)
Mar-13-25 06:43AM	Q4 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -11.10%
03:09AM	Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Mar-12-25 05:25PM	Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-07-25 06:00AM	Anika Completes Divestiture of Parcus Medical (GlobeNewswire)
Mar-01-25 06:42AM	Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now? (Insider Monkey)
Feb-26-25 08:00AM	Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 (GlobeNewswire)
Feb-25-25 08:00AM	Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference (GlobeNewswire)
Dec-23-24 04:01PM	Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESS Newswire)
Nov-22-24 04:16PM	Anika To Participate in December 2024 Investor Conferences (GlobeNewswire)
Nov-01-24 03:07AM	Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com)
Oct-31-24 11:00AM	Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics (PR Newswire) -30.67%
08:25AM	Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:18AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2024 Financial Results (GlobeNewswire)
07:00AM	Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical (GlobeNewswire)
Oct-30-24 09:19AM	Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-17-24 04:01PM	Anika Announces Third Quarter 2024 Results Conference Call Date (GlobeNewswire)
Oct-09-24 06:04PM	Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-04-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-09-24 04:45PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-09-24 07:41AM	Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? (Insider Monkey)
Aug-08-24 06:35PM	Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates (Zacks)
05:27PM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
Jul-25-24 09:00AM	Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
Jul-16-24 07:19AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-11-24 08:30AM	Anika Announces Full Market Release of the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs (GlobeNewswire)
Jul-01-24 10:35AM	Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research (GlobeNewswire)
Jun-07-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-28-24 04:05PM	Anika Enters into Cooperation Agreement with Caligan Partners (GlobeNewswire)
May-09-24 12:22PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript (Insider Monkey) -11.28%
10:59AM	Q1 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Anika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-08-24 08:57PM	ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:40PM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
04:08PM	Anika Announces CFO Transition (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jellison William R	Former Director	Aug 07 '26	Proposed Sale	21.07	16,864	355,255		Aug 07 05:28 PM
Fischetti Gary P	Director	Aug 03 '26	Buy	20.75	1,000	20,745	53,015	Aug 05 04:30 PM
Fischetti Gary P	Director	Aug 04 '26	Buy	20.32	1,000	20,315	54,015	Aug 05 04:30 PM
HENNEMAN JOHN B III	Director	May 01 '26	Buy	14.66	5,000	73,320	54,871	May 04 08:34 AM
Griffin Stephen D.	President and CEO	Apr 30 '26	Buy	12.29	12,200	149,881	36,163	Apr 30 05:22 PM

Anika Therapeutics, Inc. engages in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Executive ChairDr. Cheryl Renee Blanchard Ph.D.

PresidentMr. Stephen D. Griffin

Senior VPMr. Ian W. McLeod

Executive Director of Corporate Development & Investor RelationsMr. Matthew Hall

VP & Chief Human Resources OfficerMs. Lisa Funiciello

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Anika Therapeutics Inc

Upgrade your Finviz experience